September 28, 2023 – RDPAC is pleased to announce the list of members for the new executive committee for the term 2024-2025. The election process began on August 11, 2023, and saw active participation from the GMs of all RDPAC member companies. A total of 43 valid votes were received, resulting in the election of 13 GMs as members of the RDPAC Executive Committee for the 2024-2025 term.
The following are the members of the new executive committee:
Note: The above executive committee members are listed in alphabetical order according to the names of the member companies they represent.
On behalf of all member companies, the RDPAC office extends heartfelt congratulations to each elected member of the Executive Committee. We eagerly anticipate a future of collaboration with all member companies under the guidance of the new leadership team.
The new RDPAC Executive Committee will oversee the advancement of various association initiatives. With their support and guidance, RDPAC will continue to collaborate with key stakeholders to promote international cooperation and bridge communications between the government and the industry, advocate sustainable policies that incentivize pharmaceutical innovation to ensure novel medicines benefit Chinese patients as early and as extensively as possible. Simultaneously, we will be continuously dedicated to elevating China's pharmaceutical innovation ecosystem to foster higher-quality industry development, and to contributing to ‘Healthy China’ to improve the health and well-being of people in China.
Next, RDPAC will proceed with the election of the Chairman and two Vice-Chairpersons of the Executive Committee in the coming weeks. The election process is expected to conclude on October 25, and the election results will be announced at that time.
